Nanotechnology Now - Press Release: The Nanotech Company Names Renowned Professor, Dr. Daniel E. Morse, to SAB

Home > Press > The Nanotech Company Names Renowned Professor, Dr. Daniel E. Morse, to SAB

Abstract:
The Nanotech Company's Darrell Brookstein welcomed noted biomolecular materials researcher, Daniel E. Morse, to the Scientific Advisory Board.

The Nanotech Company Names Renowned Professor, Dr. Daniel E. Morse, to SAB

SAN DIEGO, CA | Posted on February 8th, 2007

Mr. Brookstein said, "Dan expands important expertise and brings us a powerful player. His deep military, government and industry contacts will be invaluable."

Professor Ruoslahti commented, "Great potential lies at the nexus of biology, materials science and electronics. Dan Morse is a leader in these areas and we look forward to his active role."

Dr. Morse of UCSB received his B.A. from Harvard and Ph.D from Albert Einstein College of Medicine. He's been awarded a Career Development Award from the National Institutes of Health and a Faculty Research Award from the American Cancer Society. He was elected a Regents Fellow of the Smithsonian Institution; and elected a Fellow of the American Association for the Advancement of Science. His students, including noted nanoscientist, Angela Belcher, have received international recognition.

Scientific American named him one of 50 leading technology pioneers of 2006 for his research on biologically inspired routes to nanostructured semiconductor thin films. He was honored as the 7th Kelly Lecturer in Materials and Chemistry by Cambridge and as the 3M Lecturer in Chemistry and Materials by the University of Vancouver and appointed Visiting Professor of Bio-Nano-Electronics at Toyo University.

Dr. Morse joins SAB Chairman, Erkki Ruoslahti, M.D., Ph.D., Sangeeta Bhatia, M.D., Ph.D., Pulickel Ajayan, Ph.D. and Reza Ghadiri, Ph.D. on our eminent panel of advisors.

####

About The Nanotech Company
The Nanotech Company, LLC is a merchant banking firm that invests on behalf of sophisticated investors in green-tech, drug delivery, clean-tech, alternative energy, advanced materials, solar, sensor, advanced semiconductor and drug discovery companies that employ "small" and advanced technologies. It accesses significant scientific, corporate development, and financial advisory resources. Managing Director, financial executive, Darrell Brookstein, the author of "Nanotech Fortunes" and Erkki Ruoslahti, M.D., Ph.D., Distinguished Professor and bionanoscientist, have assembled an eminent team of nanoscientists, professional services specialists, and corporate/financial development experts.

Nanotechnology.com publishes a free e-letter The Best of the NanoWeek, the investment letter, "The Small Tech Prospector" and "The Nanotechnology.com 'Small Technology' Index."

For additional information, please visit http://www.nanotechnology.com .

For more information, please click here

Contacts:
Darrell Brookstein
Managing Director
858 794 0848

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: